Related Experiment Video
Updated: Apr 11, 2026

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
Subjective cognitive concerns, amyloid-β, and neurodegeneration in clinically normal elderly
Rebecca E Amariglio1, Elizabeth C Mormino2, Alison C Pietras2
1From the Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital (R.E.A., A.C.P., G.A.M., P.V., K.A.J., R.A.S., D.M.R.), and the Departments of Neurology (R.E.A., E.C.M., G.A.M., P.V., K.A.J., R.A.S., D.M.R.) and Radiology (K.A.J.), Massachusetts General Hospital, Harvard Medical School, Boston, MA. ramariglio@partners.org.
Objective:
To determine whether neuroimaging biomarkers of amyloid-β (Aβ) and neurodegeneration (ND) are associated with greater self-reported subjective cognitive concerns (SCC) in clinically normal older individuals.
Methods:
A total of 257 participants underwent Pittsburgh compound B PET, PET with fluorodeoxyglucose (18)F, and structural MRI, as well as a battery of neuropsychological measures including several questionnaires regarding SCC. Individuals were classified into 4 biomarker groups: biomarker negative (Aβ-/ND-), amyloidosis alone (Aβ+/ND-), amyloidosis plus ND (Aβ+/ND+), and ND alone (Aβ-/ND+).
Results:
Both Aβ and ND were independently associated with greater SCC controlling for objective memory performance. By contrast, neither Aβ nor ND was associated with objective memory performance controlling for SCC. Further examination revealed greater SCC in individuals with Aβ or ND positivity compared to biomarker-negative individuals. In addition, greater SCC predicted Aβ positivity when controlling for ND status.
Conclusions:
When individuals were grouped by biomarker status, those who were positive on Aβ or ND had the highest report of SCC compared to biomarker-negative individuals. Findings were consistent when SCC was used to predict Aβ positivity. Taken together, results suggest that both Aβ and ND are associated with SCC, independent of objective memory performance. Enrichment of individuals with SCC may increase likelihood of Aβ and ND markers in potential participants for secondary prevention trials.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Cognitive Development During Adulthood
Dementia
The progression of dementia is generally gradual....
Alzheimer's Disease: Treatment
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils

